If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.00
Bid: 43.00
Ask: 45.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.651%)
Open: 44.00
High: 44.00
Low: 42.50
Prev. Close: 44.00
EBQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding in Company / Issue of Equity

13 Feb 2014 11:00

RNS Number : 0142A
Ebiquity PLC
13 February 2014
 



Ebiquity plc ("Ebiquity" or the "Company")

Holding in Company / Issue of Equity

 

Further to the announcement made by the Company on 5 February 2014, the Company was notified today that settlement of the 15,109,549 ordinary shares sold to institutional investors by Veronis Suhler Stevenson ("VSS") has now completed ("Tranche 1 Settlement").

 

The Company has also been notified that, following completion of Tranche 1 Settlement, VSS has converted in full its convertible loan notes ("Loan Note") and as a result the Company has issued 13,802,861 ordinary shares of 25p each ("Shares") to VSS (the "VSS Note Shares") representing 19.6% of the voting rights of the Company.

 

As announced on 5 February 2014, VSS has agreed to sell the 13,802,861 VSS Note Shares through an institutional placing with Numis Securities Limited acting as bookrunner at a price of 120 pence per Share. The VSS Note Shares are expected to settle on 20 February 2014 ("Tranche 2 Settlement") and the Company has applied for a total of 13,802,861 Shares to be admitted to trading on AIM on 19 February 2014 ("Admission"). Upon Admission, the VSS Note Shares will rank pari passu in all respects with the existing Shares of the Company.

 

Following Tranche 2 Settlement, VSS will not hold any Shares (and will therefore hold nil voting rights in the Company) or any Loan Note in the Company and both VSS representatives, Christopher Russell (non-executive director) and Jeffrey Stevenson (non-executive director), will step down from the Board.

 

The Company will make a further announcement following Tranche 2 Settlement.

 

Total voting rights

Following Admission, the Company's issued share capital will consist of 74,346,174 Shares and a total of 70,146,174 voting rights1.

 

Note 1

The Ebiquity plc 2000 Employee Benefit Trust holds 4,200,000 issued Shares to satisfy awards for the Company's senior management team. To date these awards have not been exercised and the trustee has agreed not to vote the Shares held by it. As such 4,200,000 Shares are treated as not carrying voting rights for the purposes of the City Code on Takeovers and Mergers.

13 February 2014

Enquiries:

Ebiquity Plc

Michael Greenlees, Chief Executive Officer

Andrew Beach, Chief Financial Officer

 

Tel. +44 (0)20 7650 9600

Instinctif Partners

Matthew Smallwood

Jamie Ramsay

Tel. +44 (0)20 7457 2020

Numis Securities Limited

Nick Westlake (NOMAD)

David Poutney, James Serjeant (Corporate Broker)

Tel. +44 (0)20 7260 1000

 

 

Numis, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is the Company's nominated adviser and broker. Numis' responsibilities as the Company's nominated adviser under the AIM Rules are owed solely to the London Stock Exchange and are not owed to the Company or to any director of the Company or to any other person. Numis is acting as bookrunner for the sellers in the placings and other arrangements detailed in this announcement and will not be responsible to anyone other than those sellers for providing the protections afforded to its clients or for providing advice in relation to the content of this announcement or any matter, transaction or arrangement discussed or referred to in it.

 

The shares being sold pursuant to the placings described above have not been (and are not being) registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and are being sold (i) outside the United States in reliance on Regulation S under Securities Act and (ii) within the United States only to persons reasonably believed to be qualified institutional buyers within the meaning of and pursuant to Rule 144A under the Securities Act in transactions exempt from the registration requirements of the Securities Act.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUAAPUPCGUW
Date   Source Headline
7th May 20247:00 amRNSFinal Results
1st May 20249:00 amRNSNotice of Investor Presentation
26th Apr 20249:18 amRNSNotice of Results
4th Apr 20247:00 amRNSDirectorate Change
20th Mar 20241:53 pmRNSStandard form for notification of major holdings
19th Mar 20244:50 pmRNSStandard form for notification of major holdings
15th Mar 202410:35 amRNSDIRECTORS’ DEALING
12th Mar 20247:00 amRNSTrading Update
11th Mar 20245:49 pmRNSStandard form for notification of major holdings
5th Mar 20248:53 amRNSStandard form for notification of major holdings
20th Nov 20234:42 pmRNSNotification of major holdings
29th Sep 20237:00 amRNSInterim Results
17th Aug 202310:12 amRNSStandard form for notification of major holdings
28th Jul 20239:20 amRNSIssue of Shares and TVR
28th Jun 20234:58 pmRNSBoard composition
5th Jun 202311:28 amRNSIssue of Shares and TVR
24th May 20235:32 pmRNSNotification of major holdings
24th May 20235:29 pmRNSAGM Statement
24th May 20234:14 pmRNSNotification of major holdings
23rd May 20236:00 pmRNSNotification of major holdings
22nd May 20235:55 pmRNSNotification of major holdings
22nd May 20239:44 amRNSIssue of Shares and TVR
19th May 20235:10 pmRNSNotification of major holdings
19th May 20233:22 pmRNSNotification of major holdings
19th May 202312:00 pmRNSNotification of major holdings
15th May 20233:45 pmRNSIssue of Shares and TVR
4th May 20237:00 amRNSNotice of Capital Markets Day
28th Apr 20231:18 pmRNSANNUAL REPORT AND ANNUAL GENERAL MEETING
17th Apr 20237:00 amRNSAppointment of Chief Financial Officer
3rd Apr 20232:06 pmRNSIssue of Shares and TVR
30th Mar 20237:01 amRNSDirectorate Change
30th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
22nd Mar 20233:19 pmRNSNotice of Investor Presentation
22nd Mar 202312:08 pmRNSNotice of Results
20th Feb 202310:23 amRNSIssue of Shares and TVR
7th Feb 20237:00 amRNSTrading Statement
23rd Jan 20235:46 pmRNSIssue of Shares and TVR
6th Jan 20235:18 pmRNSHolding(s) in Company
4th Oct 20225:13 pmRNSIssue of Shares and TVR
30th Sep 20222:16 pmRNSDIRECTORS’ DEALING
22nd Sep 20227:00 amRNSInterim Results
15th Sep 20229:03 amRNSNotice of Investor Presentation
1st Aug 202210:56 amRNSIssue of Shares and TVR
25th Jul 20227:00 amRNSTrading Update
12th Jul 20225:25 pmRNSStandard form for notification of major holdings
30th Jun 20227:00 amRNSIssue of Shares and TVR
24th May 20222:11 pmRNSIssue of Shares and TVR
19th May 202211:15 amRNSResult of AGM
25th Apr 202211:38 amRNSNotification of major holdings
22nd Apr 20224:05 pmRNSANNUAL REPORT AND ANNUAL GENERAL MEETING

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.